Skip to main content

Main menu

  • Content
    • Current Issue
    • Advance Access
    • Archive
    • Supplements
    • Special Collections
    • Topic Collections
  • For Authors
    • Instructions for Authors
    • Tips for Writing About Programs in GHSP
      • Local Voices Webinar
      • Connecting Creators and Users of Knowledge
    • Submit Manuscript
    • Publish a Supplement
    • Promote Your Article
    • Resources for Writing Journal Articles
  • About
    • About GHSP
    • Editorial Team
    • Advisory Board
    • FAQs
    • Instructions for Reviewers

User menu

  • My Alerts

Search

  • Advanced search
Global Health: Science and Practice
  • My Alerts

Global Health: Science and Practice

Dedicated to what works in global health programs

Advanced Search

  • Content
    • Current Issue
    • Advance Access
    • Archive
    • Supplements
    • Special Collections
    • Topic Collections
  • For Authors
    • Instructions for Authors
    • Tips for Writing About Programs in GHSP
    • Submit Manuscript
    • Publish a Supplement
    • Promote Your Article
    • Resources for Writing Journal Articles
  • About
    • About GHSP
    • Editorial Team
    • Advisory Board
    • FAQs
    • Instructions for Reviewers
  • Alerts
  • Find GHSP on LinkedIn
  • Visit GHSP on Facebook
  • RSS
ORIGINAL ARTICLE
Open Access

Two-Way Short Message Service (SMS) Communication May Increase Pre-Exposure Prophylaxis Continuation and Adherence Among Pregnant and Postpartum Women in Kenya

Jillian Pintye, Zoe Rogers, John Kinuthia, Kenneth K. Mugwanya, Felix Abuna, Harison Lagat, Joseph Sila, Valarie Kemunto, Jared M. Baeten, Grace John-Stewart and Jennifer A. Unger for the PrIYA Program Team
Global Health: Science and Practice March 2020, 8(1):55-67; https://doi.org/10.9745/GHSP-D-19-00347
Jillian Pintye
aDepartment of Global Health, University of Washington, Seattle, Washington, USA.
bDepartment of Biobehavioral Nursing and Health Informatics, University of Washington, Seattle, WA, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: jpintye{at}uw.edu
Zoe Rogers
aDepartment of Global Health, University of Washington, Seattle, Washington, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John Kinuthia
aDepartment of Global Health, University of Washington, Seattle, Washington, USA.
cDepartment of Obstetrics/Gynecology, Kenyatta National Hospital, Nairobi, Kenya.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kenneth K. Mugwanya
aDepartment of Global Health, University of Washington, Seattle, Washington, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Felix Abuna
cDepartment of Obstetrics/Gynecology, Kenyatta National Hospital, Nairobi, Kenya.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Harison Lagat
cDepartment of Obstetrics/Gynecology, Kenyatta National Hospital, Nairobi, Kenya.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joseph Sila
cDepartment of Obstetrics/Gynecology, Kenyatta National Hospital, Nairobi, Kenya.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Valarie Kemunto
cDepartment of Obstetrics/Gynecology, Kenyatta National Hospital, Nairobi, Kenya.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jared M. Baeten
aDepartment of Global Health, University of Washington, Seattle, Washington, USA.
dDepartment of Epidemiology, University of Washington, Seattle, Washington, USA.
eDepartment of Medicine, University of Washington, Seattle, Washington, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Grace John-Stewart
aDepartment of Global Health, University of Washington, Seattle, Washington, USA.
cDepartment of Obstetrics/Gynecology, Kenyatta National Hospital, Nairobi, Kenya.
dDepartment of Epidemiology, University of Washington, Seattle, Washington, USA.
fDepartment of Pediatrics, University of Washington, Seattle, Washington, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jennifer A. Unger
aDepartment of Global Health, University of Washington, Seattle, Washington, USA.
gDepartment of Obstetrics/Gynecology, University of Washington, Seattle, Washington, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
PreviousNext
  • Article
  • Figures & Tables
  • Supplements
  • Info & Metrics
  • Comments
  • PDF
Loading

Figures & Tables

Figures

  • Tables
  • Additional Files
  • Figure
    • Download figure
    • Open in new tab
    • Download powerpoint

    Interface of mWACh-PrEP System With Mock Data© 2019 Jillian Pintye

  • FIGURE 1
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1

    Enrollment of Women in mWACh Program at PrEP Initiation Visits, Kusumu County, Kenya

    Abbreviations: mWACh, Mobile WACh; PrEP, pre-exposure prophylaxis.

    a From 2 sites that participated in the mWACh-PrEP program.

    b PrEP initiators who were not screened for mWACh-PrEP initiated PrEP in January 2018 before mWACh-PrEP implementation, which began in February 2018.

    c PrEP initiators who were screened for mWACh-PrEP initiated PrEP between February and October 2018.

    d PrEP discontinuation was defined as either not returning for a follow-up visit or not refilling a PrEP prescription at a follow-up visit.

    e PrEP continuation was defined as attending a follow-up visit and refilling a PrEP prescription.

  • FIGURE 2a
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2a

    Women's Response Frequency to Automated SMS Over Time Since PrEP Initiation and Enrollment in mWACh-PrEP Program, Kusumu County, Kenyaa

    Abbreviations: mWACh, Mobile WACh; PrEP, pre-exposure prophylaxis; SMS, short message service.

    a Full SMS transcripts were available and analyzed for 170/190 (90%) of women who enrolled into mWACh-PrEP.

  • FIGURE 2b
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2b

    Frequency Distribution of Unprompted Question and Concern Topics Sent by Women Who Initiated PrEP to Remote Nurses Using the mWACh-PrEP Platform, Kusumu County, Kenya (N=183)a

    Abbreviations: mWACh, Mobile WACh; PrEP, pre-exposure prophylaxis; SMS, short message service.

    a Overall, 170 participants who initiated PrEP were enrolled in the mWACh-PrEP program had full transcripts available for analysis and 74 (44%) ever sent an unprompted question to a remote nurse during follow-up. Remote nurses received and responded to 183 unprompted questions in total from 74 women.

Tables

  • Figures
  • Additional Files
    • View popup
    TABLE 1.

    Characteristics of Women Screened for mWACH-PrEP and Women Who Initiated PrEP Before mWACh-PrEP,a,b by Enrollment, Kusumu County, Kenya

    Screened for mWAChInitiated PrEP Before mWACh (n=166)
    Enrolled (n=190)Ineligible or Declineda (n=144)P ValuebP Valuec
    Age, years, median (IQR)25 (22–30)23 (20–27)<.00124 (21–28).006
    Age category, No. (%)
    <18 years3 (1.6%)9 (6.3%).0411 (6.6%).06
    18–24 years89 (46.8%)80 (55.6%)77 (46.4%)
    25–29 years46 (24.2%)28 (19.4%)47 (28.3%)
    30–34 years38 (20.0%)18 (12.5%)22 (13.3%)
    ≥35 years14 (7.4%)9 (6.3%)9 (5.4%)
    Client recruitment clinic, No. (%)
    Antenatal care78 (41.1%)63 (43.8%).8480 (48.2%).19
    Postnatal care95 (50.0%)70 (48.6%)78 (47.0%)
    Family planning17 (9.0%)11 (7.6%)8 (4.8%)
    Married, No. (%)171 (90.0%)125 (86.8%).36134 (81.2%).02
    Male partner HIV status, No. (%)
    HIV-negative89 (46.8%)55 (38.2%).0475 (45.5%).81
    HIV-positive19 (10.0%)8 (5.6%)14 (8.5%)
    Unknown823 (43.2%)81 (56.3%)76 (46.1%)
    Gestational age, years, median (IQR)25 (20–28)26.5 (20–32.5).2524.5 (20–32).51
    First antenatal care visit, No. (%)24 (34.3%)16 (27.6%).4238 (52.1%).03
    Behavioral risk factors (last 6 months), No. (%)
    Had sex without a condom187 (98.4%)144 (100.0%).13164 (98.8%).77
    Exchanged sex for money or other favors0 (0.0%)2 (1.4%).101 (0.6%).28
    Diagnosed with or treated for a sexually transmitted infection1 (0.5%)2 (1.4%).410 (0.0%).35
    Forced to have sex against will5 (2.6%)4 (2.8%).938 (4.8%).27
    Experienced intimate partner violence4 (2.1%)3 (2.1%).998 (4.8%).16
    • Abbreviations: mWACh, Mobile WACh; PrEP, pr-exposure prophylaxis.

    • ↵a Overall, 3 women were eligible for mWACh-PrEP and declined participation; 141 women were ineligible.

    • ↵b Chi-sqared tests for proportions or Kruskal-Wallis tests for continuous measures, comparing women who were eligible and enrolled with women who were ineligible/declined among those screened for mWACh-PrEP.

    • ↵c Chi-sqared tests for proportions or Kruskal-Wallis tests for continuous measures, comparing women who were eligible and enrolled with women who initiated PrEP in the month before mWACh-PrEP implementation.

    • View popup
    TABLE 2.

    Representative Quotations Pertaining to Each Main Topic of Questions or Concerns and Correponding Responses, mWACh-PrEP Platforma

    TopicUnprompted Question or Concern Sent by Participants by SMSNurse's Response to Participant (Time to Response From SMS Receipt)
    PrEP dis/continuationThanks, nurse, for the concern. Just want to know the duration of taking PrEP? Because in my case, we are a discordant couple.Hello {Name}. It is important that you continue taking PrEP until your partner's viral load is suppressed. You can incorporate condoms during sexual intercourse to protect you further. We encourage that you freely share health information related to your partners care. (14 hours; participant sent SMS in the evening, nurse responded the next morning)
    Hi, I separated with my husband because of mistrust. He felt ill and was taken to the hospital, where he tested HIV-negative and malaria-positive. Should I continue using this drug? I am not a sex worker.Hello {Name}. You can continue taking your medication. But should you desire to discontinue, please come back to our clinic for further advice. I would also like to tell you that PrEP is not ONLY used by sex workers, but also those who feel they are at risk of becoming infected. (3 hours)
    Hi {Nurse's name}. If I'm abstaining from sex and I also stay alone, should I continue to use this drug?Hello {Name}. If you feel you are no longer at risk of being infected, you may stop PrEP. However, you should continue taking the drug 1 pill daily for 28 days from the last risk period. (1 hour)
    Side effectsAfter taking it (PrEP), and I vomit once a day.Nausea and vomiting is common in pregnancy and could also be a side effect of PrEP. Minor side effects like nausea and vomiting are manageable. Avoiding fatty food, eating smaller meals, and limiting spicy foods may help. PrEP minor side effects subside after a short period of time. (20 minutes)
    PrEP clarificationHey, is it true that PrEP is a type of ARV? They say it is given to HIV+ and HIV- individuals.Hello {Name}. PrEP is classified as one of the antiretroviral medications used to protect someone from HIV/AIDS. PrEP medication is given to different people depending on the substantial risks involved. Discordant couples, unknown HIV status of your sexual partner, and individuals with multiple sexual partners are some of the people at risk who could be eligible to use PrEP. (2 hours)
    Does PrEP prevent someone from conceiving?Morning {Name}. PrEP does not prevent someone from conceiving. It is safe for pregnancy as well. It can have side effects like headache, nausea, and vomiting that subsidize with time. (1 hour)
    I abide by what you people told me at the clinic, but some information I was told elsewhere is different. I heard it is not good to use this medication (PrEP) until I know my partner's status. Another issue is that PrEP is an antiretroviral medication. Can I get HIV/AIDS if I use PrEP medication for long periods?Hello, {Name}. PrEP medication helps to prevent HIV/AIDS acquisition. Not knowing your partners status is one of the risks that may lead to an individual acquiring HIV/AIDS. It is important to know your partner's status because it helps to reduce the risk of HIV acquisition. In case you want to stop PrEP, it is advisable to come back to the clinic for discontinuation. (2 hours)
    PrEP logisticsHello, Nurse. I would like to ask if it is good to take my medications before taking my meals?Hello, {Name}. It is good to take the medications after meals to avoid side effects such as nausea and vomiting. (10 minutes)
    Is it a must that I should take it (PrEP) at bedtime?Hello, it is not a must to take at bedtime. PrEP can be taken one tablet daily either in the morning, afternoon or evening. It is also advisable to be strict on the time you take the medication. In case you decide its morning hours, then every day you should take it in the morning. (19 hours; participant sent SMS in the evening, nurse responded the next morning)
    In case I forget to take PrEP medication today and then I remember the next day, can I take the medicine then?Hello, at that point in time when you remember to take medication, you should swallow 1 tablet. It is not advisable to swallow 2 tablets at once because you forgot taking the medication the previous day. You can set an alarm on your phone to act as a reminder when to take the medication. (20 hours; participant sent SMS in the evening, nurse responded the next morning)
    HIV riskI am inquiring if I have 2 partners, 1 has HIV and the other one is HIV-negative. If it happens that I have sex with the negative partner, can he get HIV because the other one is positive?How are you, {Name}. You can't transmit HIV to him because you are negative and you are on PrEP taking them faithfully. Again, if your positive partner is taking antiretrovirals as prescribed, he can't transmit HIV to you…..However, you should also use condoms when you are meeting your negative partner because you don't know if he is having multiple partners. (4 hours)
    MCH/family planningHello, I have been using Depo Provera for a long time until I stopped because of excess bleeding…I haven't experienced any of these side effects since I stopped using the injection. My monthly periods have resumed normally, 5 days, with 3 heavy days and lighter 2 days. Which method of family planning can I use without side effects?Hello, I would kindly advise you to find time and come to the hospital so that we can talk more on the other methods of family planning, so that you can be able to decide and choose one of the family planning methods that you would want to use. (2 hours)
    Now is when the baby is breastfeeding too much because she had mouth rash, she was not feeding.Hello {Name}. Breastfeeding is important for the baby because it helps in growth and development. Did you bring the child for review at the clinic regarding the oral thrush? When the baby has lesions in the mouth it can affect how the baby breastfeeds and feeding orally. (16 hours; participant sent SMS in the evening, nurse responded the next morning)
    Other (not related to PrEP)I have a problem when having sex with my husband with a condom. I experience bloating and abdominal pain. What can I do please? Should I stop having sex?Hi {Name}. You can stop having sex, but I would like you to see a doctor for further management and instructions. (23 hours; participant sent SMS on the weekend, nurse responded on Monday)
    • ↵a Some quotations have been modified from their original short message form to increase language clarity.

Additional Files

  • Figures
  • Tables
  • Supplemental material

    • Supplemental Tables -

      Supplemental Tables

PreviousNext
Back to top

In this issue

Global Health: Science and Practice: 8 (1)
Global Health: Science and Practice
Vol. 8, No. 1
March 30, 2020
  • Table of Contents
  • About the Cover
  • Index by Author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Global Health: Science and Practice.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Two-Way Short Message Service (SMS) Communication May Increase Pre-Exposure Prophylaxis Continuation and Adherence Among Pregnant and Postpartum Women in Kenya
(Your Name) has forwarded a page to you from Global Health: Science and Practice
(Your Name) thought you would like to see this page from the Global Health: Science and Practice web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Two-Way Short Message Service (SMS) Communication May Increase Pre-Exposure Prophylaxis Continuation and Adherence Among Pregnant and Postpartum Women in Kenya
Jillian Pintye, Zoe Rogers, John Kinuthia, Kenneth K. Mugwanya, Felix Abuna, Harison Lagat, Joseph Sila, Valarie Kemunto, Jared M. Baeten, Grace John-Stewart, Jennifer A. Unger
Global Health: Science and Practice Mar 2020, 8 (1) 55-67; DOI: 10.9745/GHSP-D-19-00347

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Two-Way Short Message Service (SMS) Communication May Increase Pre-Exposure Prophylaxis Continuation and Adherence Among Pregnant and Postpartum Women in Kenya
Jillian Pintye, Zoe Rogers, John Kinuthia, Kenneth K. Mugwanya, Felix Abuna, Harison Lagat, Joseph Sila, Valarie Kemunto, Jared M. Baeten, Grace John-Stewart, Jennifer A. Unger
Global Health: Science and Practice Mar 2020, 8 (1) 55-67; DOI: 10.9745/GHSP-D-19-00347
del.icio.us logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Statistics from Altmetric.com

Jump to section

  • Article
    • ABSTRACT
    • INTRODUCTION
    • METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • Acknowledgements
    • Notes
    • REFERENCES
  • Figures & Tables
  • Supplements
  • Info & Metrics
  • Comments
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • Building HIV/AIDS prevention communication strategies through community-informed formative research for a biobehavioural couple-based HIV prevention intervention for Latino men who have sex with men
  • Process Evaluation for the Delivery of a Water, Sanitation and Hygiene Mobile Health Program: Randomized Controlled Trial of the PICHA7 Mobile Health Program
  • Google Scholar

More in this TOC Section

  • Uganda Public Health Fellowship Program’s Contributions to Malaria Control Programs 2015–2022: Strategies, Implementation Challenges, and Opportunities
  • A Comprehensive Strategy to Mitigate Institutional Maternal Mortality: Lessons From a Quality Improvement Initiative in Brazilian Maternity Hospitals
  • Research and Learning Priorities for a Surgical Obstetrics and Family Planning Project Implementing in Low- and Middle-Income Countries: Results of an Expert Consultation
Show more ORIGINAL ARTICLE

Similar Articles

Johns Hopkins Center for Communication Programs

Follow Us On

  • LinkedIn
  • Facebook
  • RSS

Articles

  • Current Issue
  • Advance Access Articles
  • Past Issues
  • Topic Collections
  • Most Read Articles
  • Supplements

More Information

  • Submit a Paper
  • Instructions for Authors
  • Instructions for Reviewers

About

  • About GHSP
  • Advisory Board
  • FAQs
  • Privacy Policy
  • Contact Us

© 2026 Creative Commons Attribution 4.0 International License. ISSN: 2169-575X

Powered by HighWire